ClinicalTrials.Veeva

Menu

High Dose Rate Interstitial Brachytherapy With Three Dimensional Printing Template for Recurrent Gynecologic Tumors

P

Peking University

Status

Unknown

Conditions

Cervical Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT04127435
M2019338-1

Details and patient eligibility

About

This is a single-center study.Eligible patients will have histologically proven pelvic recurrence of cervical cancer after radiotherapy .

Full description

The results of treatment, examination and follow-up of patients with recurrent cervical cancer after radiotherapy who recieved imaging guided three dimensional printing personalized template assisted with 192Ir high dose rate interorganizational braided therapy were statistically analyzed .

Enrollment

50 estimated patients

Sex

Female

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with histologically confirmed pelvic recurrence of cervical cancer.
  • Age ≥ 18 years and ≤ 75 years.
  • Previous accept pelvic radiotherapy;
  • Karnofsky ≥60;
  • Patients reject or cannot tolerate surgery;
  • Received 192Ir high dose rate intertissue salvage therapy;
  • Ultrasound guidance or computed tomography guidance;
  • Regular review and follow-up.

Exclusion criteria

  • Patients participated in clinical trials of other drugs within four weeks;
  • The patient had a previous history of bleeding, and any bleeding event with severity rating of CTCAE5.0 or above occurred within 4 weeks prior to screening;
  • There are any puncture taboos.
  • Patients with severe cardiovascular and cerebrovascular diseases.
  • Unable to treat as planned.
  • Patients lack major indicators and cannot participate in post-treatment review and follow-up.

Trial design

50 participants in 1 patient group

High-Dose-Rate 192Ir Brachytherapy
Description:
1. All patients underwent computed tomography (CT) 3-5 days before surgery. The collimation is 2.5 mm and CT Planning System. 2. Delineation of the gross tumor volume (GTV) and adjacent organs at risk (OARs); 3. Determination of the needle tract of the implanted insertion direction, distribution, and depth. Then calculation of the dose distribution of the target volume and OARs. 4. Depending on B-TPS data, we establish a digital model for the individual template. 5. Local anesthesia or intraspinal anesthesia was induced in all patients. The three-dimensional printing noncoplanar templates (3D-PNCT) was placed on the surface of the treatment area of the patient. The 3D-PNCT was aligned accurately with the outer-contour features. Through the guide hole of the 3D-PNCT, we inserted to pre-planned depths. 6. Delineation of the GTV and design planning . 7. Connect the source tube and 192Ir high dose rate interorganizational brinotherapy 8. At the end pressed to stop bleeding.

Trial contacts and locations

1

Loading...

Central trial contact

Ping Jiang, MD; Junjie Wang, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems